Autism Spectrum Disorder (ASD) is characterized by deficits in social interaction and communication, as well as the presence as stereotyped behaviour and restrictive interests [@bib0010]. In the past, all psychiatric problems in children and adults with autism used to be attributed to autism itself. However, an increasing number of studies are arguing for accepting behaviours and symptoms that had been considered additional or associated features of ASD as potentially indicating the presence of comorbidities warranting additional diagnosis. Individuals diagnosed with ASD often present other psychiatric disorders, such as attention deficit and hyperactivity disorder (ADHD), anxiety disorders, mood alterations, etc. ([@bib0185]). It has been suggested that comorbidity will generally lead to more severe impairments as a result of the cumulative effects of having more than one disorder [@bib0070]. Autism is generally a lifelong condition beginning in childhood and with pathological outcomes in adulthood. Outcomes are often described as difficulties or issues in finance, employment and socialization [@bib0050]. When other problematic symptoms are recognized as manifestation of comorbid psychiatric disorders, rather than just isolated symptoms, more specific treatment is possible. For this reason, comorbidity identification should include those symptoms which are sufficient for a comorbidity diagnosis and those isolated symptoms which can be relevant as descriptors of individual phenotypes such as eating behaviour problems, behaviour difficulties such as self-aggression or hetero-aggression.

One of the goals of the new classification (DSM-5) must be to identify subgroups of ASD, including comorbidity disorders, which may be important to understand the biological mechanisms, the clinical results and the reactions of the individuals with ASD to the treatment. It has been proposed a phenotypic characterization to improve the classification of ASD based not only on the specific items of ASD, but involving other specific characterizations such as cognitive and adaptive function, language skills, comorbidity, other medical conditions and other psychiatric features in order to standardize the clinical characteristics of individuals with ASD [@bib0085].

The publication of the fifth edition of the DSM has intensified a debate since the announcement of the changes in diagnostic criteria proposed by the APA. There is an increment of studies that open many questions about the diagnostic validity of the DSM-5 ([@bib0175], [@bib0180], [@bib0205]). One of the important controversies is the diagnosis of ASD. The DSM-5 unifies the first and the second domain into a single category which include meeting all three distinctions of Social Communication and Interaction (SCI). The DSM-5 classification assembles the Pervasive Developmental Disorders (PDD) with different diagnostic subtypes into a single dimensional category of ASD, grouped by severity levels [@bib0150], [@bib0235]). There is an accord in different articles, stating that the new classification requires more severe symptomatology for the diagnosis ([@bib0075], [@bib0135], [@bib0210]).

The DSM-5, with difference to DSM-IV-TR, admits comorbidity with Attention Deficit and Hyperactivity Disorders (ADHD) in patients diagnosed with ASD. Many studies showed a high percentage of children diagnosed with ASD, who require health services, have ADHD comorbidity ([@bib0030], [@bib0090], [@bib0190], [@bib0240]). Also, estimates of impairing anxiety range from 11--84% in school-aged children with ASD and as many as 40% meet criteria for an anxiety disorder ([@bib0100], [@bib0215], [@bib0220]). These reviews note a wide range of estimates attributable to differences in the sample source, sample size and assessment methods employed. These rates of anxiety disorders in youth with ASD are nearly two-fold higher than current estimates in typically developing children ([@bib0045]). Other reports indicate that Separation Anxiety and Generalized Anxiety ([@bib0065]) also occur at higher than expected rates in youth with ASD. Although the majority of previous studies involved clinic-based samples, community-based studies also indicate that children with ASD are at greater risk of anxiety ([@bib0185]).

Because of pure phenomenological reasons, the Obsessive Compulsive Disorders (OCD) and autism include the behavioural appearances (e.g., the compulsions in the OCD; rituals and routines in ASD) and cognitive appearances (the obsession in the OCD; equality insistence and worries in ASD). Although the form and content of these symptoms are different in both disorders ([@bib0145], [@bib0245]; autism tends to involve less complex forms which are perhaps due to the existence of cognitive disorders and/or language. Despite of any overlap, the profile of repetitive behaviours in autism and OCD is also differentiable ([@bib0020]). For example, individuals with OCD usually do not have repetitive motor behaviours often associated with autism (e.g., hand flapping). In addition, individuals with OCD exhibit more cleaning, checking and counting behaviours, while individuals with autism engage in more hoarding, ordering, touching/tapping, and self-inflicted injuries ([@bib0145]). The underlying causes of repetitive behaviour are unclear, although the modulation of arousal is usually suggested for ASD, and anxiety for OCD ([@bib0245]).

In addition, children with early symptoms of neuropsychiatric disorders present a higher frequency of behavioural eating problems ([@bib0015]) compared with children who do not have any disorders [@bib0040]. Some published studies of children diagnosed with ASD, show an estimated 90% prevalence of eating problems ([@bib0105]). According to another study, the prevalence of eating problems was 0.6% in the control study population and, among children with eating problems, 40% were screened positive for ADHD and/or ASD ([@bib0165]). Similarly, self-harm, self-injurious behaviours and hetero-aggression are very common in children diagnosed with Pervasive Developmental Disorder (PDD). In fact, the drugs used in ASD are aimed at treating behavioural and symptomatic problems, despite these symptoms are not part of the core symptoms of ASD ([@bib0200]). For this reason, the characterization of ASD should consider the assessment, not only of the comorbid disorders but also, the independent symptoms that might influence on the functionality or on the medical treatment of this population.

Therefore, the main goal of the present study was to analyse the clinical diagnostic comorbidities and the isolated psychiatric symptoms which can be relevant as descriptors of autistic\'s phenotype. A comparative study was carried out between a sample of patients with PDD diagnosis according to the DSM-IV-TR criteria and a sample of patients with clinical diagnosis of ASD according to DSM-5. It is hypothesized that the group of patients who met the DSM-5 criteria have more severe symptomatology, not only regarding the severity of core autistic symptoms but also in relation with different comorbid conditions.

Method {#sec0005}
======

Participants {#sec0010}
------------

The recruitment of patients was via educational institutions in Málaga (Southern Spain). According to the census of individuals between 5 and 15 years registered in the province of Malaga and data from the Spanish National Institute of Statistics, the number of individuals enrolled in school was 56,839. The study was conducted accordingly with the Helsinski Declaration and was approved by the Local Community Ethics Committee. See flow diagram in [Figure 2](#fig0010){ref-type="fig"}.Figure 2Flow diagram.

Individual and parents' interviews were made in the Unit of Child and Adolescents Mental Health in Carlos Haya Hospital in Malaga (Southern Spain), after signing the informed consent. Psychiatrists and psychologists with experience in children and adolescents carried out the assessments. Firstly, it was confirmed the community diagnosis for PDD by the clinical interview and according to the checklist DSM-IV-TR/ICD-10 scale. In term of demographic features; the mean age of participants was 10.62 and 82% of the sample were males.

Instruments and Procedure {#sec0015}
-------------------------

In order to confirm the clinical diagnosis of PDD, the DSM-IV-TR/ICD-10 Checklists were selected. Psychometric properties of the DSM-IV-TR/ICD-10 Checklist have been shown to be satisfactory as inter-rater reliability (r = .89), test-retest reliability (r = .97), and internal consistency (α = .95) were all robust ([@bib0080], [@bib0125], [@bib0235]). The DSM-5 clinical diagnosis for ASD was assessed by child psychiatrists according to the DSM-5 manual, published in May, 2013. As we can see in the [Figure 1](#fig0005){ref-type="fig"}, and consistently with the DSM-5, patients should have meet the three items of the criteria A, belonging to the domain of sociability and at least two items for the criteria B, restrictive interest and/or repetitive behaviour domain (RRB). The DSM-IV-TR/ICD-10 checklist scale was also used for this purpose. Finally, the total sample of patients diagnosed with PDD according to DSM-IV-TR was divided into two groups: (1) DSM-5 group; individuals who met also the DSM-5 criteria for ASD and (2) Non DSM-5 group; individuals who only met DSM-IV-TR criteria for PDD (not DSM-5 criteria).Figure 1Proposed Diagnostic and Statistical Manual of Mental Disorders, 5^th^ edition (DSM-5) criteria and associated features to be considered when characterizing autism spectrum disorder (ASM) samples ([@bib0085], with permission).

Variables of psychiatric comorbidities were obtained by the clinical assessment, and parents' interviews, using the DSM-IV-TR criteria. The comorbid conditions studied were: (1) Attention Deficit and Hyperactivity Disorder and (2) Obsessive Compulsive Disorder. Moreover, the following independent psychiatric symptoms were assessed the same way: (1) Anxious or too fearful, (2) Physically harms or hurts self on purpose, (3) Physically attacks people, (4) Self-harm enough to leave tooth marks or break skin and (5) Eating behavioural problems.

The prevalence and frequency of some of these symptoms (1, 2, 3), were collected according to *The Nisonger Child Behaviour Rating Form* (NCBRF) (Problem behaviour subscale) ([@bib0005]). The NCBRF ([@bib0155]) is a factor-analytically derived scale with items rated from; did not occur or was no a problem (0) to behaviour occurred a lot or was a severe problem (3). There are two versions of the NCBRF: a parent and teacher version. The Conduct subscale of the NCBRF has been used as an outcome measure in placebo controlled trials of children with mild developmental disabilities ([@bib0035], [@bib0195]). It has also been used to characterize a large sample of children with ASD ([@bib0110]). Concerning the item of (4) self-harm enough to leave tooth marks or break skin, the symptom was collected through the clinical history of the emergency visits or medical specialist consultation due to this cause (YES/NO).

Finally, the information about eating behaviour problems was collected during the clinical interview with the parents. It was codified according to the frequency of appearance, similar to the NCBRF scale; from did not occur or was no a problem (0) to behaviour occurred a lot or was a severe problem (3).

Severity of symptomatology was assessed by *Autism Spectrum Disorder Inventory* (IDEA) ([@bib0170]). It is an inventory that includes 12 dimensions of development, divided into 4 areas (Social development, language and communication, anticipation and flexibility, symbolizing). Each dimension is scored from 0 (no qualitative disorder) to 8 (maximum involvement level) at intervals of 2 (0, 2, 4, 6, 8), being able to use odd scores when considering that the symptomatology is at an intermediate point between 2 consecutive items. The inventory was built with the aim of assess the severity of the core features of ASD.

Statistical analysis {#sec0020}
--------------------

Statistical analysis was performed using SPSS™ 21.0 with 1000 samples bootstrapping. After checking the linear model assumptions (Kolmogorov--Smirnov and Shapiro--Wilk tests) dimensional variables and frequencies were compared by parametric or non-parametric tests as appropriate (Chi Square Test and Student *t*-test). The bivariate association between the two groups (DSM-5 vs. Non DSM-5) and independent variables (comorbid disorders, other psychiatric symptoms and severity of symptoms) was initially explored using either two-way cross-tabulations or mean comparisons. We assumed *a* significance level of *p* ≤ .05.

Results {#sec0025}
=======

Clinical and sociodemographic distribution {#sec0030}
------------------------------------------

The [Table 1](#tbl0005){ref-type="table"} shows the distribution of the number of patients who met DSM-5 criteria (DSM-5 group) and patients who did not (Non DSM-5) and the prevalence of the different Autism Spectrum Disorders (ASD) subgroups according to the DSM-IV TR \[Autistic Disorder, Asperger\'s and pervasive developmental disorder-not otherwise specified (PDD-NOS)\]. There were no significant differences between both groups in relation with the distribution of ASD subtypes (*χ*^*2*^ =  0.99; *p = .61*). Also, no significant differences in age was found between both groups (*t*-Student = -0.47; *p* = .64) (*mean age*: 10.62; *SD*: 2.99). The 82% of the sample were males and the ethnicity of the sample was 100% Caucasian.Table 1Distribution of the number of patients who met DSM-5 criteria (DSM-5 group) and patients who did not (Non DSM-5) showing the prevalence of the different Autism Spectrum Disorders (ASD) subgroups and comorbidity with Attention Deficit Hyperactivity Disorder (ADHD), Obsessive Compulsive Disorder (OCD), Anxiety, Eating behavior problems, Auto-aggression, Hetero-aggression and Self-harm. Statistical differences between both groups are described.Table 1No DSM-5\
Count (%)DSM-5\
Count (%)Total\
Count (%)*p*ASD subtypesAutism17 (25.8%)17 (29.8%)34 (27.6%).61Asperger13 (19.7%)14 (24.6%)27 (22%)PDD-NOS36 (54.5%)26 (45.6%)62 (50.4%)Total66 (100%)57 (100%)123 (100%)ADHDNo33 (50%)19 (33.3%)52 (42.3%).06Yes33 (50%)38 (66.7%)71 (57.7%)Total66 (100%)57 (100%)123 (100%)OCDNo51 (77.3%)22 (38.6%)73 (59.3%).0001Yes15 (22.7%)35 (61.4%)50 (40.7%)Total66 (100%)57 (100%)123 (100%)AnxietyNo occur6 (9.5%)4 (7%)10 (8.3%).09Occasional39 (61.9%)24 (42.1%)63 (52.5%)Quite often4 (6.3%)5 (8.8%)9 (7.5%)Severe problem14 (22.2%)24 (42.1%)38 (31.7%)Eating behaviour problemsNo occur33 (52.4%)16 (28.6%)49 (41.2%).05Occasional12 (19%)17 (30.4%)29 (24.4%)Quite often4 (6.3%)3 (5.4%)7 (5.9%)Severe problem14 (22.2%)20 (35.7%)34 (28.6%)Auto-aggressionNo occur42 (66.7%)31 (54.4%)73 (60.8%).57Occasional5 (7.9%)6 (10.5%)11 (9.2%)Quite often4 (6.3%)6 (10.5%)10 (8.3%)Severe problem12 (19%)14 (24.6%)26 (21.7%)Hetero-aggressionNo occur40 (64.5%)31 (56.4%)71 (60.7%).31Occasional12 (19.4%)12 (21.8%)24 (20.5%)Quite often1 (1.6%)5 (9.1%)6 (5.1%)Severe problem9 (14.5%)7 (12.7%)16 (13.7%)Self-harmNo54 (81.8%)41 (71.9%)95 (77.2%).20Yes12 (18.2%)16 (28.1%)28 (22.8%)Total66 (100%)57 (100%)123 (100%)

Comorbidity with Attention Deficit Hyperactivity Disorder (ADHD) {#sec0035}
----------------------------------------------------------------

The [Table 1](#tbl0005){ref-type="table"} illustrates the distribution of the number of participants who had clinical comorbidity with ADHD. Statistical analysis showed a non-significance value (*χ*^*2*^ = 3.48; *p* = .06), although it had a tendency toward the significance, as there was a higher percentage of participants with comorbidities in the DSM-5 group.

Comorbidity with Obsessive Compulsive Disorder (OCD) {#sec0040}
----------------------------------------------------

As it can be seen in the [Table 1](#tbl0005){ref-type="table"}, statistically significant differences between both groups were observed (*χ*^*2*^ = 18.96; *p* = .0001). In conclusion, patients fulfilling the DSM-5 criteria for ASD had higher prevalence of OCD diagnosis.

Anxiety or too fearful {#sec0045}
----------------------

Assessing the frequency of symptoms of anxiety or too fear between both groups, it was observed a tendency of having more severe problems in the group of participants who met DSM-5 criteria (63%), although there were no statistically significant differences between both groups (*χ*^*2*^ = 6.43; *p* = .09). See [Table 1](#tbl0005){ref-type="table"}.

Eating behaviour problems {#sec0050}
-------------------------

The [Table 1](#tbl0005){ref-type="table"} shows the distribution and the frequency of participants who presented eating behaviour problems. Statistically significant differences were found between both groups in relation with this symptom (*χ*^*2*^ = 7.57; *p* = .05). A higher prevalence of eating behaviour problems was observed in participants who met the criteria for ASD according to the DSM- 5.

Auto-aggression, hetero-aggression, self-harm {#sec0055}
---------------------------------------------

Comorbidities with auto-aggression, hetero-aggression and self-harm, are shown in [Table 1](#tbl0005){ref-type="table"}, respectively. When both groups were compared, not significant differences were found (*χ*^*2*^ = 2.01; *p* = .57), (*χ*^*2*^ = 3.65; *p* = .31) and (*χ*^*2*^ = 1.70; *p* = .20), respectively.

Severity of Autism Spectrum Disorder {#sec0060}
------------------------------------

In order to assess the severity of the core autistic symptoms, *The Autism Spectrum Inventory* (IDEA) was used ([Table 2](#tbl0010){ref-type="table"}). The null hypothesis of equal variances (Levene\'s test), was rejected and it was concluded that there was a significant difference between the variances of these measures. Consequently, the statistical analysis Kolmogorov-Smirnov was used and it showed that the group of patients who met DSM-5 criteria had more severe symptoms than the Non DSM-5 group with statistical significant differences *(p* = .0001).Table 2Comparative study between No Autism Spectrum Disorders (ASD) DSM-5 and ASD DSM 5 group for severity of autistic symptoms. Mean (*SD*) \[CI 95\].Table 2Total Sample\
(*n* = 120)No-ASD DSM-5\
(*n* = 63)ASD DSM-5\
(*n* = 57)*pIDEA*43(8.82)\
\[41.41 to 44.59\]38,86 (8.69)\
\[36.67 to 41.04\]47,58 (6.41)\
\[45.88 to 49.28\].0001

Discussion {#sec0065}
==========

Based on the data presented in this study, there is no question that comorbid symptomatology are quite prevalent in children with ASD. Variables such as specific behavioural symptoms, ADHD, OCD and severity of symptoms, likely have an influence on the autism individual\'s experience. The present study shows that the new classification DSM-5 requires more severe symptomatology for the diagnosis of ASD and also, the group of patients who met the DSM-5 criteria for ASD, are more likely to develop psychiatric comorbidities, specifically OCD and eating problems. Previous studies have supported the hypothesis of the DSM-5 could significantly improve the specificity at the expense of loss sensitivity in ASD ([@bib0010], [@bib0055], [@bib0085], [@bib0230]). However, to the best of our knowledge, no previous studies have compared both classifications in term of severity and comorbidities in this population. Therefore, this study suggests that DSM-5 classification has been able to identify children with the most severe symptomology; however, it might fail to identify those with high functioning autism or less severe symptomatology. Consequently, in term of clinical implication, the DSM-5 criteria could have a high impact in the diagnosis of ASD. Authors of the present study also support the proposal of a phenotypic characterization, to improve the DSM-5 classification for ASD.

Methodology issues and further research {#sec0070}
---------------------------------------

By addressing methodological issues that limit the findings of this study, future studies can contribute noticeably to our better understanding about the impact of the new classification in this population and answer more pointed scientific questions in relation with the phenotypic characterization. The present study did not employ any independent 'gold standard' confirmation for the ASD diagnoses \[i.e., Autism Diagnostic Interview-Revised (ADI-R); ([@bib0120]) or Autism Diagnostic Observation Schedule (ADOS) [@bib0115])\]; instead, including children based on community and clinical diagnosis with the DSM-IV-TR/ICD-10 Checklists confirmation.

This study was also limited by the fact that the diagnosis of ASD according to DSM-5 was completed using the items of DSM-IV-TR/ICD-10 Checklists. Although this method has been also used previously in other studies ([@bib0025], [@bib0130]), new objective measures will need to be developed in order to accurately capture the patients who meet ASD criteria according to DSM-5 classification if valid and reliable measures cannot be identified at the current time.

In relation with the assessment for comorbid psychiatric symptoms such as eating disorders, anxiety, auto-and hetero-aggressiveness and self-arm, research on the applicability of traditional measures of childhood psychiatric symptoms, is sorely needed. Until we have consensus on 'best practice' measures, a healthy skepticism is called for with respect to the precision of the tools we currently have for measuring symptoms of comorbid problems in children with ASD. Assessment of global severity is another important consideration in treatment outcome research; yet, there is little guidance on its evidence-based assessment for children with ASD ([@bib0225]).

One of the main strength of the methodology in this study was in relation with the representativeness of the sample of participants. The present study drew their ASD sample from a large population-derived, non-clinical patients. Clinical samples are often needed to accrue an adequate number of participants and for ensuring statistical power, but such samples can make it difficult to generalize findings. Clinic-based samples are likely not representative of all children with ASD in many important respects, such as degree of parental investment, level of behaviour disturbance, etc.

Main results {#sec0075}
------------

The findings of the current study support the overall a priori hypothesis. It was found that participants who met DSM-5 criteria had higher prevalence of clinical comorbidities and severity. According to the analysis of comorbidity with attention deficit disorder and hyperactivity (ADHD), the results showed that there were no statistical significant differences between both groups. However, there is a tendency toward higher prevalence in the DSM-5 group. The absence of a statistical significance could be due the sample size of patients with comorbid ADHD (*n* = 71). According to the last review, the prevalence has been remarkably heterogeneous, ranging from 4% to 94% (weighted mean prevalence = 48%; [@bib0060]). For example, [@bib0160] obtained a lower percentage of 29% as it focused on a non-clinical recruitment to avoid over diagnosis. Congruently, the current study was focused on non-clinical participants and we found a prevalence of 57.7%. These findings support the hypothesis that the comorbidity with ADHD may constitute a distinctive phenotype of ASD, and these children may be at a greater risk of involvement and socially adaptive problems. Moreover, ADHD is a condition that produces high academic dysfunctionality and therefore, exacerbates the academic and social needs of children who present comorbidity with ASD. This is important because participants with both conditions are given various treatments or strength requirements than those which have only ASD. These results are congruent with a growing number of studies that have shown that both pathologies can co-exist ([@bib0160]).

In the present study the results have showed that participants meeting DSM-5 criteria for ASD have more OCD comorbidity. The ASD diagnosis according to DSM-5 requires greater rigidity in the behavioural domain, unlike in the DSM-IV-TR. One of the most significant changes in the DSM-5 classification is the higher requirement in the area of repetitive and restrictive behaviour, requiring two of the four items compared to the DSM-IV-TR criteria where only one item was required for the diagnosis of PDD ([@bib0095], [@bib0140]). For that reason, the similarities that exist between routines and rituals behaviour in ASD and compulsions in OCD; obsession in the OCD and equality insistence and worries in ASD, indicate that clinicians should make the assessment very carefully in order to make a correct differential diagnosis. If the assessment is only focused on the DSM-5 criteria, the comorbid diagnosis of OCD might be imprecise in individuals with ASD. Therefore, exploration into the overlapping and distinct phenotypic presentations of individuals with comorbid presentations (e.g., ASD with OCD) versus presentations of OCD or ASD singly may be of potential importance for understanding the biological markers of these disorders. Further genetic and neuro-imaging studies are needed in order to better understand this approach.

In addition, the present study found significant differences with eating behaviour problems between both groups, supporting the hypothesis of having more comorbidity in the DSM-5 group. Previous published studies of children diagnosed with ASD showed an estimated eating problem which reaches 90% of prevalence ([@bib0105]). However, in this study we obtained a lower percentage between 28.6% and 51% because we focused on a non-clinical recruitment to avoid over diagnosis.

Even without a clinical diagnosis, the results found that 31.7% of patients had severe problems with anxiety, congruent with the review of [@bib0215], in which a percentage of 40% was found. Anxiety is an important factor in the daily lives of many children and adolescents with ASD diagnosis. Children and adolescents with ASD generally take longer to communicate their symptoms of anxiety due to their communication problems, many of which only manifest themselves internally (i.e., constant worry). These limitations make it difficult for people with ASD to be diagnosed because of the difficulties to express their own feelings or problems. Unfortunately, there is little clarity on how best to assess other psychiatric comorbid symptoms in this population and the direct impact on the ASD severity.

Finally, these findings do support the proposal of [@bib0085], in order to highlight the importance of carrying out a phenotypic characterization to improve the DSM-5 classification, based not only on the specific core symptoms of ASD but also in their comorbidities and other factors that may influence on the functionality of this complex spectrum of autism ([Fig. 1](#fig0005){ref-type="fig"}).

Conclusions {#sec0080}
===========

This study supports the hypothesis that the DSM-5 classification includes patients who are more prone to clinical severity not only in relation to the core items of ASD, but also at the level of psychiatric comorbidities. Patients who met DSM-5 criteria had more comorbidity with OCD, eating behaviour problems and severity than patients who only met the DSM-IV-TR criteria. Future studies can contribute markedly to our better understanding the effect of the new classification in this population and answer more pointed scientific questions in relation with the phenotypic categorization of children with autism spectrum disorder.
